Lite'n Foamy E2 Sanitizing Handwash (Benzalkonium Chloride, 0.13%), Net Contents: 1 US Gallon/ 3....
FDA Drug Recall #D-0362-2021 — Class II — March 29, 2021
Recall Summary
| Recall Number | D-0362-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 29, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Spartan Chemical Co Inc |
| Location | Maumee, OH |
| Product Type | Drugs |
| Quantity | 2,152 containers |
Product Description
Lite'n Foamy E2 Sanitizing Handwash (Benzalkonium Chloride, 0.13%), Net Contents: 1 US Gallon/ 3.79 Liters per gallon container, For Institutional and Industrial Use Only, Spartan Chemical Company, Inc., 1110 Spartan Drive, Maumee, OH 43537 USA. UPC 7 53727 26116 1 NDC: 64009-333-95
Reason for Recall
CGMP Deviations
Distribution Pattern
Nationwide USA and Puerto Rico; Mexico
Lot / Code Information
Lot, expiry: Lot 538882, exp 1/22/2023
Other Recalls from Spartan Chemical Co Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0360-2021 | Class II | foamyiQ Lemon Blossom Hand Sanitizer (benzalkon... | Mar 29, 2021 |
| D-0364-2021 | Class II | Lite'n Foamy Healthcare Personnel Handwash (Chl... | Mar 29, 2021 |
| D-0361-2021 | Class II | Antiseptic Hand Cleaner (Chloroxylenol, 1.0%), ... | Mar 29, 2021 |
| D-0359-2021 | Class I | Lite'n Foamy Lemon Blossom Hand Sanitizer (benz... | Mar 29, 2021 |
| D-0363-2021 | Class II | Lite'n Foamy Eucalyptus Mint Sanitizing Handwas... | Mar 29, 2021 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.